Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""antiretroviral therapy"" wg kryterium: Temat


Tytuł :
The scale-up of antiretroviral therapy coverage was strongly associated with the declining tuberculosis morbidity in Africa during 2000-2018.
Autorzy :
Boah M; Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin 150081, China; Ghana Health Service, Private Mail Bag, Bolgatanga, Upper East Region, Ghana.
Jin B; Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin 150081, China; Department of Preventive Medicine, Qiqihar Medical University, Qiqihar 161006, China.
Adampah T; Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin 150081, China; Education, Culture and Health Opportunities (ECHO) Research Group International, Aflao, Ghana.
Wang W; Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin 150081, China; Institute of Cell Biotechnology, China and Russia Medical Research Center, Harbin Medical University, Harbin 150081, China.
Wang K; Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin 150081, China; Institute of Cell Biotechnology, China and Russia Medical Research Center, Harbin Medical University, Harbin 150081, China. Electronic address: .
Pokaż więcej
Źródło :
Public health [Public Health] 2021 Feb; Vol. 191, pp. 48-54. Date of Electronic Publication: 2021 Jan 25.
Typ publikacji :
Journal Article
MeSH Terms :
AIDS-Related Opportunistic Infections/*epidemiology
Anti-HIV Agents/*therapeutic use
Antiretroviral Therapy, Highly Active/*statistics & numerical data
HIV Infections/*drug therapy
Tuberculosis/*epidemiology
Adolescent ; Adult ; Africa/epidemiology ; Aged ; Anti-HIV Agents/adverse effects ; Antiretroviral Therapy, Highly Active/methods ; Epidemics ; Female ; HIV Infections/complications ; HIV Infections/epidemiology ; Humans ; Incidence ; Male ; Middle Aged ; Prevalence ; Public Health Surveillance ; Retrospective Studies ; Tuberculosis/etiology ; Young Adult
Czasopismo naukowe
Tytuł :
Inflammation in Relation to Intensity and Duration of Cigarette Smoking Among People Living with HIV.
Autorzy :
Poudel KC; Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, 715 North Pleasant St., 301 Arnold House, Amherst, MA, 01003-9304, USA. .; Institute for Global Health, University of Massachusetts Amherst, Amherst, MA, USA. .
Poudel-Tandukar K; College of Nursing, University of Massachusetts Amherst, Amherst, MA, USA.
Bertone-Johnson ER; Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA, USA.; Department of Biostatistics & Epidemiology, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA, USA.
Pekow P; Department of Biostatistics & Epidemiology, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA, USA.
Vidrine DJ; Department of Health Outcomes and Behavior, Moffit Cancer Center, Tampa, FL, USA.
Pokaż więcej
Źródło :
AIDS and behavior [AIDS Behav] 2021 Mar; Vol. 25 (3), pp. 856-865. Date of Electronic Publication: 2020 Sep 28.
Typ publikacji :
Journal Article
MeSH Terms :
Antiretroviral Therapy, Highly Active*
C-Reactive Protein/*metabolism
Cigarette Smoking/*adverse effects
HIV Infections/*drug therapy
Inflammation/*etiology
Adult ; C-Reactive Protein/analysis ; Cigarette Smoking/blood ; HIV Infections/epidemiology ; Humans ; Inflammation/blood ; Inflammation/epidemiology ; Interviews as Topic ; Longitudinal Studies ; Middle Aged ; Nepal/epidemiology ; Qualitative Research ; Smoking Cessation/methods
Czasopismo naukowe
Tytuł :
Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection.
Autorzy :
Lanzafame M; Unità Semplice Organizzativa 'Diagnosi e Terapia dell'infezione da HIV', Ospedale Policlinico 'G.B. Rossi',Verona, Italy. Electronic address: .
Lattuada E; Unità Complessa di Malattie Infettive, Ospedale Policlinico 'G.B. Rossi',Verona, Italy.
Gottardo R; Unità Complessa di Medicina Legale, Ospedale Policlinico 'G.B. Rossi',Verona, Italy.
Piacentini D; Unità Complessa di Malattie Infettive, Ospedale Policlinico 'G.B. Rossi',Verona, Italy.
Be G; Unità Complessa di Malattie Infettive, Ospedale Policlinico 'G.B. Rossi',Verona, Italy.
Razzaboni E; Unità Complessa di Malattie Infettive, Ospedale Policlinico 'G.B. Rossi',Verona, Italy.
Cattaneo P; Unità Complessa di Malattie Infettive, Ospedale Policlinico 'G.B. Rossi',Verona, Italy.
Luise D; Unità Complessa di Malattie Infettive, Ospedale Policlinico 'G.B. Rossi',Verona, Italy.
Vento S; Faculty of Medicine, University of Puthisastra, Phnom Penh, Cambodia.
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Mar; Vol. 57 (3), pp. 106290. Date of Electronic Publication: 2021 Jan 26.
Typ publikacji :
Letter; Observational Study
MeSH Terms :
Anti-HIV Agents/*therapeutic use
Antiretroviral Therapy, Highly Active/*methods
HIV Infections/*drug therapy
Heterocyclic Compounds, 3-Ring/*therapeutic use
Lamivudine/*therapeutic use
Oxazines/*therapeutic use
Piperazines/*therapeutic use
Pyridones/*therapeutic use
Reverse Transcriptase Inhibitors/*therapeutic use
Adult ; Aged ; Anti-HIV Agents/adverse effects ; Antiretroviral Therapy, Highly Active/adverse effects ; Cohort Studies ; Drug Therapy, Combination ; Female ; Heterocyclic Compounds, 3-Ring/adverse effects ; Humans ; Lamivudine/adverse effects ; Male ; Middle Aged ; Oxazines/adverse effects ; Piperazines/adverse effects ; Pyridones/adverse effects ; Reverse Transcriptase Inhibitors/adverse effects
Raport
Tytuł :
Is age and not antiretroviral therapy the strongest risk factor for chronic pain in HIV-infected population?
Autorzy :
Kowalski M; Polish Medical Air Rescue, Clinical Governance Department, Warsaw, Poland.; Department of Adults' Infectious Diseases, Medical Faculty, Medical University of Warsaw, Warsaw, Poland.
Horban A; Department of Adults' Infectious Diseases, Medical Faculty, Medical University of Warsaw, Warsaw, Poland.
Slomka B; Department of Rehabilitation, Public Central Teaching Clinical Hospital University Clinical Center, Medical University of Warsaw, Warsaw, Poland. .
Shahnazaryan K; Department of Rehabilitation, Medical Faculty, Medical University of Warsaw, Warsaw, Poland.
Rongies W; Department of Rehabilitation, Public Central Teaching Clinical Hospital University Clinical Center, Medical University of Warsaw, Warsaw, Poland.; Department of Rehabilitation, Medical Faculty, Medical University of Warsaw, Warsaw, Poland.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Feb 01; Vol. 21 (1), pp. 136. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Journal Article
MeSH Terms :
Antiretroviral Therapy, Highly Active*
Chronic Pain/*epidemiology
HIV Infections/*epidemiology
Adult ; Age Factors ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Poland/epidemiology ; Prevalence ; Prospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Cross-sectional evaluation of perceived health care provider engagement, self-efficacy, and ART adherence in people living with HIV/AIDS.
Autorzy :
Edmonds KA; Department of Psychology, University of Toledo, Toledo, OH, USA.
Aspiras OG; Department of Psychology, University of Toledo, Toledo, OH, USA.
Rose JP; Department of Psychology, University of Toledo, Toledo, OH, USA.
Gratz KL; Department of Psychology, University of Toledo, Toledo, OH, USA.
Pinkston MM; Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University, Providence, RI, USA.
Naifeh JA; Department of Psychiatry, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Konkle-Parker DJ; Department of Medicine/Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, MS, USA.
Tull MT; Department of Psychology, University of Toledo, Toledo, OH, USA.
Pokaż więcej
Źródło :
AIDS care [AIDS Care] 2021 Feb; Vol. 33 (2), pp. 154-158. Date of Electronic Publication: 2019 Dec 17.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Professional-Patient Relations*
Self Efficacy*
Antiretroviral Therapy, Highly Active/*psychology
HIV Infections/*drug therapy
Health Personnel/*psychology
Medication Adherence/*statistics & numerical data
Adult ; Anti-Retroviral Agents/therapeutic use ; Antiretroviral Therapy, Highly Active/adverse effects ; Cross-Sectional Studies ; Female ; HIV Infections/psychology ; Humans ; Male ; Medication Adherence/psychology
Czasopismo naukowe
Tytuł :
Trajectories of fertility intentions among women living with HIV in South Africa.
Autorzy :
Rucinski KB; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.
Powers KA; Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA.
Pettifor AE; Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA.
Black V; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.; Faculty of Health Sciences, Clinical Microbiology and Infectious Diseases, University of the Witwatersrand, Johannesburg, South Africa.
Pence BW; Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA.
Chi BH; Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Rees H; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.
Schwartz SR; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.
Pokaż więcej
Źródło :
AIDS care [AIDS Care] 2021 Feb; Vol. 33 (2), pp. 180-186. Date of Electronic Publication: 2020 Feb 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Antiretroviral Therapy, Highly Active*
Counseling*
Fertility*
Intention*
HIV Infections/*drug therapy
HIV Infections/*psychology
Adolescent ; Adult ; Female ; HIV Infections/epidemiology ; Humans ; Male ; Pregnancy ; Prospective Studies ; Reproductive Health Services ; South Africa/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Effect of highly active antiretroviral treatment on TB incidence among HIV infected children and their clinical profile, retrospective cohort study, South West Ethiopia.
Autorzy :
Tiruneh F; Department of Midwifery, College of Health Science, Mizan Tepi University, PO box 260, Mizan Teferi, Ethiopia. .
Deyas Y; Department of Midwifery, College of Health Science, Mizan Tepi University, PO box 260, Mizan Teferi, Ethiopia.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Dec 08; Vol. 10 (1), pp. 21468. Date of Electronic Publication: 2020 Dec 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiretroviral Therapy, Highly Active*
Anti-Retroviral Agents/*therapeutic use
HIV Infections/*drug therapy
Tuberculosis/*epidemiology
Adolescent ; Child ; Child, Preschool ; Coinfection/drug therapy ; Coinfection/epidemiology ; Ethiopia/epidemiology ; Female ; HIV Infections/epidemiology ; Humans ; Incidence ; Infant ; Male ; Retrospective Studies ; Tuberculosis/drug therapy
Czasopismo naukowe
Tytuł :
Immunological and virological efficacy of different antiretroviral regimens initiated during acute/recent HIV infection.
Autorzy :
Ambrosioni J; HIV Unit and Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona.
Farrera J; Nefrology Service, Hospital del Mar.
de Lazzari E; HIV Unit and Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona.
Nicolás D; HIV Unit and Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona.
Manzardo C; HIV Unit and Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona.
Hernández-Meneses MM; HIV Unit and Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona.
Mosquera MM; Laboratory of Virology, Microbiology Service, Hospital Clinic-ISGLOBAL, University of Barcelona.
Ligero C; HIV Unit and Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona.
Marcos MA; Laboratory of Virology, Microbiology Service, Hospital Clinic-ISGLOBAL, University of Barcelona.
Sánchez-Palomino S; Laboratory of Retrovirology and Viral Immunopathology, AIDS Research Group, IDIBAPS, Barcelona, Spain.
Fernández E; HIV Unit and Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona.
Plana M; Laboratory of Retrovirology and Viral Immunopathology, AIDS Research Group, IDIBAPS, Barcelona, Spain.
Miró JM; HIV Unit and Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona.
Pokaż więcej
Corporate Authors :
Hospital Clinic Acute/Recent HIV Study Group
Źródło :
AIDS (London, England) [AIDS] 2020 Dec 01; Vol. 34 (15), pp. 2269-2274.
Typ publikacji :
Journal Article
MeSH Terms :
Antiretroviral Therapy, Highly Active*
HIV Infections*/drug therapy
HIV Infections*/immunology
HIV Infections*/virology
HIV Integrase Inhibitors*/therapeutic use
CD4 Lymphocyte Count ; CD4-CD8 Ratio ; Cohort Studies ; Humans ; Retrospective Studies ; Viral Load
Czasopismo naukowe
Tytuł :
Alcohol consumption increases non-adherence to ART among people living with HIV enrolled to the community-based care model in rural northern Uganda.
Autorzy :
Adrawa N; The AIDS Support Organization, Center of Clinical Excellence, Gulu, Uganda.; Department of Business Studies, Faculty of Management Studies, Islamic University in Uganda, Mbale, Uganda.; Institute of Public Health and Management, Clarke International University, Kampala, Uganda.
Alege JB; Institute of Public Health and Management, Clarke International University, Kampala, Uganda.
Izudi J; Institute of Public Health and Management, Clarke International University, Kampala, Uganda.; Department of Community Health, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Nov 24; Vol. 15 (11), pp. e0242801. Date of Electronic Publication: 2020 Nov 24 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Antiretroviral Therapy, Highly Active*
Medication Adherence*
Alcohol Drinking/*adverse effects
HIV Infections/*drug therapy
Adult ; Anti-Retroviral Agents/administration & dosage ; Anti-Retroviral Agents/adverse effects ; Cross-Sectional Studies ; Female ; HIV Infections/epidemiology ; HIV Infections/virology ; HIV-1/drug effects ; HIV-1/pathogenicity ; Humans ; Male ; Middle Aged ; Risk Factors ; Uganda/epidemiology
Czasopismo naukowe
Tytuł :
Newly diagnosed HIV positive children: a unique index case to improve HIV diagnosis and linkage to care of parents.
Autorzy :
Neary J; Departments of Global Health, University of Washington, Seattle, WA, USA.
Njuguna IN; Departments of Epidemiology, University of Washington, Seattle, WA, USA.; Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.
Cranmer LM; Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA.
Otieno VO; Kenya Medical Research Institute, Kisumu, Kenya.
Mugo C; Departments of Global Health, University of Washington, Seattle, WA, USA.; Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.
Okinyi HM; Department of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Benki-Nugent S; Departments of Global Health, University of Washington, Seattle, WA, USA.
Richardson BA; Departments of Global Health, University of Washington, Seattle, WA, USA.; Departments of Biostatistics, University of Washington, Seattle, WA, USA.
Stern J; Departments of Biostatistics, University of Washington, Seattle, WA, USA.
Maleche-Obimbo E; Department of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Wamalwa DC; Department of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
John-Stewart GC; Departments of Global Health, University of Washington, Seattle, WA, USA.; Departments of Epidemiology, University of Washington, Seattle, WA, USA.; Departments of Medicine, University of Washington, Seattle, WA, USA.; Departments of Pediatrics, University of Washington, Seattle, WA, USA.
Wagner AD; Departments of Global Health, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło :
AIDS care [AIDS Care] 2020 Nov; Vol. 32 (11), pp. 1400-1405. Date of Electronic Publication: 2020 Feb 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Antiretroviral Therapy, Highly Active*
HIV Infections*/diagnosis
HIV Infections*/drug therapy
Parents/*psychology
Child ; Child, Preschool ; Delivery of Health Care ; Early Diagnosis ; Female ; Humans ; Infant ; Infant, Newborn ; Kenya ; Male ; Mothers
Czasopismo naukowe
Tytuł :
Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection.
Autorzy :
Gay CL; Department of Medicine, University of North Carolina at Chapel Hill (UNC) School of Medicine.; UNC Chapel Hill HIV Cure Center.
Neo DT; UNC Gillings School of Global Public Health.
Devanathan AS; UNC Eshelman School of Pharmacy, Chapel Hill.
Kuruc JD; Department of Medicine, University of North Carolina at Chapel Hill (UNC) School of Medicine.; UNC Chapel Hill HIV Cure Center.
McGee KS; UNC Gillings School of Global Public Health.; Department of Medicine, Duke University, Durham.
Schmitz JL; Department of Microbiology and Immunology, UNC, Chapel Hill.
Sebastian J; Q Solutions, Miami Blvd, Morrisville.
Shaheen NJ; Department of Medicine, University of North Carolina at Chapel Hill (UNC) School of Medicine.
Ferrari G; Department of Surgery, Duke University, Durham.
McKellar M; Department of Medicine, Duke University, Durham.
Fiscus SA; Department of Medicine, University of North Carolina at Chapel Hill (UNC) School of Medicine.; Department of Microbiology and Immunology, UNC, Chapel Hill.
Hicks CB; ViiV Healthcare, Research Triangle.
Robertson K; Department of Medicine, University of North Carolina at Chapel Hill (UNC) School of Medicine.; Department of Neurology, UNC, Chapel Hill, North Carolina, USA.
Kashuba ADM; UNC Eshelman School of Pharmacy, Chapel Hill.
Eron JJ; Department of Medicine, University of North Carolina at Chapel Hill (UNC) School of Medicine.; UNC Chapel Hill HIV Cure Center.
Margolis DM; Department of Medicine, University of North Carolina at Chapel Hill (UNC) School of Medicine.; UNC Chapel Hill HIV Cure Center.; Department of Microbiology and Immunology, UNC, Chapel Hill.
Pokaż więcej
Źródło :
AIDS (London, England) [AIDS] 2020 Nov 01; Vol. 34 (13), pp. 1923-1931.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Antiretroviral Therapy, Highly Active*
Anti-HIV Agents/*therapeutic use
Darunavir/*pharmacokinetics
HIV Infections/*drug therapy
HIV-1/*drug effects
Ritonavir/*pharmacokinetics
Adult ; CD4 Lymphocyte Count ; Darunavir/therapeutic use ; Drug Resistance, Viral ; Drug Therapy, Combination ; Female ; HIV/genetics ; Humans ; Male ; Middle Aged ; Pilot Projects ; Ritonavir/therapeutic use ; Treatment Outcome ; Viral Load/drug effects
Czasopismo naukowe
Tytuł :
Persistent high levels of immune activation and their correlation with the HIV-1 proviral DNA and 2-LTR circles loads, in a cohort of Mexican individuals following long-term and fully suppressive treatment.
Autorzy :
Orta-Resendiz A; Molecular Virology Unit, Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: .
Viveros-Rogel M; Molecular Virology Unit, Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Fuentes-Romero LL; Molecular Virology Unit, Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Vergara-Mendoza M; Molecular Virology Unit, Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Romero-Rodriguez DP; Flow Cytometry Core Facility, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Muñoz-Lopez M; Molecular Virology Unit, Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Zancatl-Diaz ML; Molecular Virology Unit, Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Vidal-Laurencio EY; Molecular Virology Unit, Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Rodriguez-Diaz RA; Molecular Virology Unit, Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Soto-Ramirez LE; Molecular Virology Unit, Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: .
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2020 Nov; Vol. 100, pp. 184-192. Date of Electronic Publication: 2020 Aug 20.
Typ publikacji :
Journal Article
MeSH Terms :
Antiretroviral Therapy, Highly Active*
Lymphocyte Activation*
DNA, Viral/*genetics
HIV Infections/*immunology
HIV-1/*immunology
Terminal Repeat Sequences/*genetics
Adult ; Anti-HIV Agents/therapeutic use ; Cohort Studies ; Female ; HIV Infections/drug therapy ; HIV Infections/virology ; HIV-1/genetics ; HIV-1/physiology ; Humans ; Interleukin-7/immunology ; Male ; Middle Aged ; Prospective Studies ; Viral Load ; Virus Replication
Czasopismo naukowe
Tytuł :
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon.
Autorzy :
Calmy A; Division of Infectious Diseases, HIV-AIDS Unit, Geneva University Hospitals, Geneva, Switzerland. Electronic address: .
Tovar Sanchez T; TransVIHMI, University of Montpellier, IRD, INSERM, 34394 Montpellier, France.
Kouanfack C; Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon; Day Stay Hospital, Central Hospital of Yaoundé, Henri-Dunant, Yaoundé, Cameroon; ANRS Cameroon site, Central Hospital of Yaoundé, Henri-Dunant, Yaoundé, Cameroon.
Mpoudi-Etame M; Regional Military Hospital Number 1, Yaoundé, Cameroon.
Leroy S; TransVIHMI, University of Montpellier, IRD, INSERM, 34394 Montpellier, France.
Perrineau S; TransVIHMI, University of Montpellier, IRD, INSERM, 34394 Montpellier, France.
Lantche Wandji M; ANRS Cameroon site, Central Hospital of Yaoundé, Henri-Dunant, Yaoundé, Cameroon.
Tetsa Tata D; ANRS Cameroon site, Central Hospital of Yaoundé, Henri-Dunant, Yaoundé, Cameroon.
Omgba Bassega P; Cité Verte District Hospital, Cité Verte District, Yaoundé, Cameroon.
Abong Bwenda T; ANRS Cameroon site, Central Hospital of Yaoundé, Henri-Dunant, Yaoundé, Cameroon.
Varloteaux M; ANRS Cameroon site, Central Hospital of Yaoundé, Henri-Dunant, Yaoundé, Cameroon.
Tongo M; Emerging and Re-emerging Diseases Research Centre, IMPM, Sise à Ngoa-Ekelle, Yaoundé, Cameroon.
Mpoudi-Ngolé E; Emerging and Re-emerging Diseases Research Centre, IMPM, Sise à Ngoa-Ekelle, Yaoundé, Cameroon.
Montoyo A; Office of International Research and Collaboration, ANRS Inserm, Paris, France.
Mercier N; Office of Clinical Trial Safety, ANRS Inserm, Paris, France.
LeMoing V; TransVIHMI, University of Montpellier, IRD, INSERM, 34394 Montpellier, France; Montpellier University Hospital Centre, Montpellier, France.
Peeters M; TransVIHMI, University of Montpellier, IRD, INSERM, 34394 Montpellier, France.
Reynes J; TransVIHMI, University of Montpellier, IRD, INSERM, 34394 Montpellier, France; Montpellier University Hospital Centre, Montpellier, France.
Delaporte E; TransVIHMI, University of Montpellier, IRD, INSERM, 34394 Montpellier, France; Montpellier University Hospital Centre, Montpellier, France.
Pokaż więcej
Corporate Authors :
New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group
Źródło :
The lancet. HIV [Lancet HIV] 2020 Oct; Vol. 7 (10), pp. e677-e687.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiretroviral Therapy, Highly Active*/adverse effects
Antiretroviral Therapy, Highly Active*/methods
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
HIV Infections/*virology
HIV-1/*drug effects
Adult ; Alkynes ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Benzoxazines/administration & dosage ; CD4 Lymphocyte Count ; Cyclopropanes ; Duration of Therapy ; Female ; Heterocyclic Compounds, 3-Ring/administration & dosage ; Humans ; Middle Aged ; Oxazines ; Piperazines ; Pyridones ; Treatment Outcome ; Viral Load ; Young Adult
Czasopismo naukowe
Tytuł :
[Access to the management of HIV infected children: Overview of the healthcare supply in Cameroon in 2014].
Autorzy :
Penda CI; Department of clinical sciences, Faculty of medicine and pharmaceutical sciences, University de Douala, Douala, Cameroun; Laquintinie de Douala hospital, Douala, Cameroun. Electronic address: .
Zoung Kanyi Bissek AC; Department of medicine et specialties, Faculty of biomedical sciences, University of Yaoundé 1, Yaoundé, Cameroun; Operational research division, Cameroonian ministry of public health, Yaoundé, Cameroun.
Téjiokem MC; Epidemiology and public health department, Pasteur center of Cameroon, Member of the Institut Pasteur International Network, Yaoundé, Cameroun.
Sofeu CL; Epidemiology and public health department, Pasteur center of Cameroon, Member of the Institut Pasteur International Network, Yaoundé, Cameroun; University of Bordeaux, Inserm Bordeaux Population health U1219 (Biostatistics), Bordeaux, France.
Eboumbou Moukoko EC; Epidemiology and public health department, Pasteur center of Cameroon, Member of the Institut Pasteur International Network, Yaoundé, Cameroun; Department of the biological sciences, Faculty of medicine and the pharmaceutical sciences, University of Douala, Cameroun.
Ateba Ndongo F; Operational research division, Cameroonian ministry of public health, Yaoundé, Cameroun; Chantal Biya foundation, Mother-and-Child center of Yaoundé, Yaoundé, Cameroun.
Njock LR; Laquintinie de Douala hospital, Douala, Cameroun; Department of surgery and specialties, Faculty of medicine and the pharmaceutical sciences, University of Douala, Douala, Cameroun.
Koki Ndombo PO; Chantal Biya foundation, Mother-and-Child center of Yaoundé, Yaoundé, Cameroun; Departement of pediatrics, Faculty of biomedical sciences, University of Yaoundé 1, Yaoundé, Cameroun.
Pokaż więcej
Transliterated Title :
Accès à la prise en charge de l’infection VIH pédiatrique – État des lieux de l’offre des soins au Cameroun en 2014.
Źródło :
Revue d'epidemiologie et de sante publique [Rev Epidemiol Sante Publique] 2020 Aug; Vol. 68 (4), pp. 243-251. Date of Electronic Publication: 2020 Jul 04.
Typ publikacji :
Journal Article
MeSH Terms :
Antiretroviral Therapy, Highly Active*
Pediatrics*/organization & administration
Pediatrics*/statistics & numerical data
HIV Infections/*therapy
Health Services Accessibility/*statistics & numerical data
Adult ; Anti-HIV Agents/supply & distribution ; Anti-HIV Agents/therapeutic use ; Anti-Retroviral Agents/supply & distribution ; Anti-Retroviral Agents/therapeutic use ; Cameroon/epidemiology ; Child ; Cross-Sectional Studies ; Delivery of Health Care/organization & administration ; Delivery of Health Care/standards ; Delivery of Health Care/statistics & numerical data ; Female ; HIV ; HIV Infections/epidemiology ; Health Services Accessibility/standards ; Healthcare Disparities/standards ; Healthcare Disparities/statistics & numerical data ; Humans ; Male ; Medical Staff/statistics & numerical data ; Middle Aged ; Socioeconomic Factors
Czasopismo naukowe
Tytuł :
Risk factors for delayed viral suppression on first-line antiretroviral therapy among persons living with HIV in Haiti, 2013-2017.
Autorzy :
Rich SN; Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, United States of America.; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States of America.
Cook RL; Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, United States of America.
Yaghjyan L; Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, United States of America.
Francois K; Programme National de Lutte contre le SIDA, Ministère de la Santé Publique et de la Population, Port au Prince, Haïti.
Puttkammer N; Department of Global Health, International Training and Education Center for Health (I-TECH), University of Washington, Seattle, WA, United States of America.
Robin E; Programme National de Lutte contre le SIDA, Ministère de la Santé Publique et de la Population, Port au Prince, Haïti.
Bae J; College of Pharmacy, Institute for Pharmaceutical Outcomes and Policy, University of Kentucky, Lexington, KY, United States of America.
Joseph N; National Alliance of State and Territorial AIDS Directors, Port au Prince, Haiti.
Pessoa-Brandão L; National Alliance of State and Territorial AIDS Directors, Port au Prince, Haiti.
Delcher C; College of Pharmacy, Institute for Pharmaceutical Outcomes and Policy, University of Kentucky, Lexington, KY, United States of America.; National Alliance of State and Territorial AIDS Directors, Port au Prince, Haiti.; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, KY, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Oct 29; Vol. 15 (10), pp. e0240817. Date of Electronic Publication: 2020 Oct 29 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-HIV Agents/*therapeutic use
Antiretroviral Therapy, Highly Active/*methods
HIV Infections/*drug therapy
HIV-1/*drug effects
Adolescent ; Adult ; Anti-HIV Agents/adverse effects ; Antiretroviral Therapy, Highly Active/adverse effects ; Child ; Child, Preschool ; Female ; HIV Infections/epidemiology ; HIV Infections/virology ; HIV-1/pathogenicity ; Haiti/epidemiology ; Humans ; Lamivudine/therapeutic use ; Male ; Middle Aged ; Nevirapine/adverse effects ; Nevirapine/therapeutic use ; Risk Factors ; Viral Load/drug effects ; Young Adult ; Zidovudine
Czasopismo naukowe
Tytuł :
Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection.
Autorzy :
Gopalakrishnan V; Johns Hopkins University Department of Biomedical Engineering, 3510 N Charles Street, Baltimore, MD, 21218, USA.
Bose E; School of Nursing at MGH Institute of Health Professions, 36 1st Ave, Charlestown, MA, 02129, USA.
Nair U; Ragon Institute and Harvard Medical School, 400 Tech Square, Cambridge, MA, 02129, USA.
Cheng Y; College of the Holy Cross, 1 College St, Worcester, MA, 01610, USA.
Ghebremichael M; Ragon Institute and Harvard Medical School, 400 Tech Square, Cambridge, MA, 02129, USA. .; Ragon Institute of Harvard, MGH and MIT, 400 Technology Square, Cambridge, MA, 02129, USA. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2020 Oct 15; Vol. 20 (1), pp. 756. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article
MeSH Terms :
Antiretroviral Therapy, Highly Active*
CD4 Lymphocyte Count*
Coinfection*
CD4-Positive T-Lymphocytes/*immunology
HIV Infections/*drug therapy
HIV Infections/*immunology
Tuberculosis/*complications
AIDS-Related Opportunistic Infections ; Biomarkers/analysis ; CD4-Positive T-Lymphocytes/virology ; Child ; Child, Preschool ; Female ; Ghana ; HIV Infections/microbiology ; HIV Infections/mortality ; Humans ; Kaplan-Meier Estimate ; Male ; ROC Curve ; Retrospective Studies ; Treatment Outcome ; Tuberculosis/virology
Czasopismo naukowe
Tytuł :
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy : A Cohort Study.
Autorzy :
Del Amo J; Ministry of Health, Madrid, Spain (J.D., R.P.).
Polo R; Ministry of Health, Madrid, Spain (J.D., R.P.).
Moreno S; University Hospital Ramón y Cajal and HIV Network of Excellence, Madrid, Spain (S.M.).
Díaz A; Ministry of Health, HIV Network of Excellence, and Institute of Health Carlos III, Madrid, Spain (A.D.).
Martínez E; HIV Network of Excellence, Madrid, and University Hospital Clinic, Barcelona, Spain (E.M.).
Arribas JR; HIV Network of Excellence and University Hospital La Paz, IdiPAZ, Madrid, Spain (J.R.A.).
Jarrín I; HIV Network of Excellence and Institute of Health Carlos III, Madrid, Spain (I.J.).
Hernán MA; Harvard T.H. Chan School of Public Health and Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts (M.A.H.).
Pokaż więcej
Corporate Authors :
The Spanish HIV/COVID-19 Collaboration
Źródło :
Annals of internal medicine [Ann Intern Med] 2020 Oct 06; Vol. 173 (7), pp. 536-541. Date of Electronic Publication: 2020 Jun 26.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiretroviral Therapy, Highly Active*
Coronavirus Infections/*epidemiology
HIV Infections/*drug therapy
Pneumonia, Viral/*epidemiology
Adenine/analogs & derivatives ; Adult ; Aged ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/mortality ; Dideoxynucleosides ; Drug Combinations ; Emtricitabine ; Female ; HIV Infections/mortality ; Hospitalization/statistics & numerical data ; Humans ; Incidence ; Intensive Care Units/statistics & numerical data ; Lamivudine ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/mortality ; Reverse Transcriptase Polymerase Chain Reaction ; SARS-CoV-2 ; Severity of Illness Index ; Spain/epidemiology ; Tenofovir
Czasopismo naukowe
Tytuł :
Mechanisms from Food Insecurity to Worse HIV Treatment Outcomes in US Women Living with HIV.
Autorzy :
Weiser SD; Division of HIV, Infectious Disease and Global Medicine, Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.
Sheira LA; Division of HIV, Infectious Disease and Global Medicine, Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.
Palar K; Division of HIV, Infectious Disease and Global Medicine, Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.
Kushel M; Division of General Internal Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco (UCSF), San Francisco, California, USA.
Wilson TE; Department of Community Health Sciences, State University of New York Downstate Medical Center, School of Public Health, Brooklyn, New York, USA.
Adedimeji A; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA.
Merenstein D; Department of Family Medicine, Georgetown University Medical Center, Washington, District of Columbia, USA.
Cohen M; Department of Medicine, Stroger Hospital, Chicago, Illinois, USA.
Turan JM; Department of Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Metsch L; Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, New York, USA.
Adimora AA; School of Medicine and UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Ofotokun I; Division of Infectious Diseases, Department of Medicine, Emory University, Grady Healthcare System, Atlanta, Georgia, USA.
Wentz E; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Tien PC; Department of Medicine, University of California, San Francisco and Medical Service, Department of Veteran Affairs Medical Center, San Francisco, California, USA.
Frongillo EA; Department of Health Promotion, Education, and Behavior, University of South Carolina, Columbia, South Carolina, USA.
Pokaż więcej
Źródło :
AIDS patient care and STDs [AIDS Patient Care STDS] 2020 Oct; Vol. 34 (10), pp. 425-435. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Food Insecurity*
Medication Adherence*
Anti-HIV Agents/*therapeutic use
Antiretroviral Therapy, Highly Active/*methods
HIV Infections/*drug therapy
Antiretroviral Therapy, Highly Active/psychology ; CD4 Lymphocyte Count ; Child ; Female ; Food Supply ; HIV Infections/psychology ; Humans ; Mental Health ; Treatment Outcome ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial.
Autorzy :
Venter WDF; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: .
Sokhela S; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Simmons B; Department of Infectious Disease, Imperial College London, London, UK.
Moorhouse M; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Fairlie L; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.
Mashabane N; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Serenata C; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Akpomiemie G; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Masenya M; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.
Qavi A; School of Public Health, Imperial College London, London, UK.
Chandiwana N; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
McCann K; School of Public Health, Imperial College London, London, UK.
Norris S; South African Medical Research Council and Wits Developmental Pathways for Health Research Unit, Department of Pediatrics, University of the Witwatersrand, Johannesburg, South Africa.
Chersich M; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.
Maartens G; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Lalla-Edward S; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Vos A; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
Clayden P; HIV i-Base, London, UK.
Abrams E; ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, NY, USA; Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Arulappan N; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Hill A; Department of Translational Medicine, Liverpool University, Liverpool, UK.
Pokaż więcej
Źródło :
The lancet. HIV [Lancet HIV] 2020 Oct; Vol. 7 (10), pp. e666-e676.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiretroviral Therapy, Highly Active*
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
HIV Infections/*virology
HIV-1/*drug effects
Adenine/administration & dosage ; Adenine/analogs & derivatives ; Adolescent ; Adult ; Alkynes ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Benzoxazines/administration & dosage ; Body Composition ; Body Weight ; Cyclopropanes ; Duration of Therapy ; Emtricitabine/administration & dosage ; Female ; Heterocyclic Compounds, 3-Ring/administration & dosage ; Humans ; Male ; Middle Aged ; Oxazines ; Piperazines ; Pyridones ; Tenofovir/administration & dosage ; Treatment Outcome ; Viral Load ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies